
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13677799
[patent_doc_number] => 20160377633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => BCL-2-LIKE PROTEIN 11 SRM/MRM ASSAY
[patent_app_type] => utility
[patent_app_number] => 15/262736
[patent_app_country] => US
[patent_app_date] => 2016-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15262736
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/262736 | Bcl-2-like protein 11 SRM/MRM assay | Sep 11, 2016 | Issued |
Array
(
[id] => 11381632
[patent_doc_number] => 20170007688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 15/252999
[patent_app_country] => US
[patent_app_date] => 2016-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12394
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15252999
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/252999 | VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES | Aug 30, 2016 | Abandoned |
Array
(
[id] => 11625923
[patent_doc_number] => 20170136108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS'
[patent_app_type] => utility
[patent_app_number] => 15/249035
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 72607
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15249035
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/249035 | NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS | Aug 25, 2016 | Abandoned |
Array
(
[id] => 13235019
[patent_doc_number] => 10130693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
[patent_app_type] => utility
[patent_app_number] => 15/249121
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 39
[patent_no_of_words] => 68647
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15249121
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/249121 | Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers | Aug 25, 2016 | Issued |
Array
(
[id] => 11627313
[patent_doc_number] => 20170137503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/245838
[patent_app_country] => US
[patent_app_date] => 2016-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 23601
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15245838
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/245838 | ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF | Aug 23, 2016 | Abandoned |
Array
(
[id] => 11704630
[patent_doc_number] => 20170173130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'CANCER VACCINES AND VACCINATION METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/227552
[patent_app_country] => US
[patent_app_date] => 2016-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15089
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15227552
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/227552 | Cancer vaccines and vaccination methods | Aug 2, 2016 | Issued |
Array
(
[id] => 13343665
[patent_doc_number] => 20180223372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => IDENTIFICATION OF PREDICTIVE BIOMARKERS ASSOCIATED WITH WNT PATHWAY INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/749855
[patent_app_country] => US
[patent_app_date] => 2016-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15749855
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/749855 | IDENTIFICATION OF PREDICTIVE BIOMARKERS ASSOCIATED WITH WNT PATHWAY INHIBITORS | Aug 2, 2016 | Abandoned |
Array
(
[id] => 13326061
[patent_doc_number] => 20180214568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS
[patent_app_type] => utility
[patent_app_number] => 15/747620
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747620
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747620 | Antibody-drug conjugates for targeting CD56-positive tumors | Jul 28, 2016 | Issued |
Array
(
[id] => 17044963
[patent_doc_number] => 11098131
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies
[patent_app_type] => utility
[patent_app_number] => 15/748634
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 47863
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748634
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748634 | Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies | Jul 27, 2016 | Issued |
Array
(
[id] => 13329313
[patent_doc_number] => 20180216194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 15/747780
[patent_app_country] => US
[patent_app_date] => 2016-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747780
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747780 | COMPOSITIONS AND METHODS FOR DETECTING PANCREATIC CANCER | Jul 24, 2016 | Abandoned |
Array
(
[id] => 16822783
[patent_doc_number] => 20210138076
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2021-05-13
[patent_title] => CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
[patent_app_type] => utility
[patent_app_number] => 15/747501
[patent_app_country] => US
[patent_app_date] => 2016-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747501
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747501 | CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES | Jul 24, 2016 | Abandoned |
Array
(
[id] => 16822783
[patent_doc_number] => 20210138076
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2021-05-13
[patent_title] => CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
[patent_app_type] => utility
[patent_app_number] => 15/747501
[patent_app_country] => US
[patent_app_date] => 2016-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747501
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747501 | CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES | Jul 24, 2016 | Abandoned |
Array
(
[id] => 13311465
[patent_doc_number] => 20180207269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => Methods of Treating CD166-Expressing Cancer
[patent_app_type] => utility
[patent_app_number] => 15/745582
[patent_app_country] => US
[patent_app_date] => 2016-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745582
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745582 | Methods of treating CD166-expressing cancer | Jul 17, 2016 | Issued |
Array
(
[id] => 14868073
[patent_doc_number] => 20190284278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => HUMANIZED OR CHIMERIC CD3 ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 15/744317
[patent_app_country] => US
[patent_app_date] => 2016-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744317
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/744317 | Humanized or chimeric CD3 antibodies | Jul 13, 2016 | Issued |
Array
(
[id] => 13672721
[patent_doc_number] => 20160375094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => TYROSINE-PHOSPHORYLATED WBP2, A NOVEL CANCER TARGET AND BIOMARKER
[patent_app_type] => utility
[patent_app_number] => 15/209538
[patent_app_country] => US
[patent_app_date] => 2016-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15209538
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/209538 | TYROSINE-PHOSPHORYLATED WBP2, A NOVEL CANCER TARGET AND BIOMARKER | Jul 12, 2016 | Abandoned |
Array
(
[id] => 12546312
[patent_doc_number] => 10011645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
[patent_app_type] => utility
[patent_app_number] => 15/202388
[patent_app_country] => US
[patent_app_date] => 2016-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 31
[patent_no_of_words] => 51850
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15202388
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/202388 | Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | Jul 4, 2016 | Issued |
Array
(
[id] => 13781027
[patent_doc_number] => 20190004052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => METHODS OF CHARACTERISING CANCER
[patent_app_type] => utility
[patent_app_number] => 15/737613
[patent_app_country] => US
[patent_app_date] => 2016-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737613
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737613 | METHODS OF CHARACTERISING CANCER | Jun 19, 2016 | Abandoned |
Array
(
[id] => 16290126
[patent_doc_number] => 10766962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => FZD7 specific antibodies and vaccines to treat cancer and control stem cell function
[patent_app_type] => utility
[patent_app_number] => 15/736646
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 27
[patent_no_of_words] => 27350
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736646
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/736646 | FZD7 specific antibodies and vaccines to treat cancer and control stem cell function | Jun 15, 2016 | Issued |
Array
(
[id] => 11348927
[patent_doc_number] => 20160367667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'Compositions and Methods for Diagnosing and Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 15/167510
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 34158
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15167510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/167510 | Compositions and Methods for Diagnosing and Treating Cancer | May 26, 2016 | Abandoned |
Array
(
[id] => 17783610
[patent_doc_number] => 11406715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Methods of treating HER2-positive metastatic breast cancer
[patent_app_type] => utility
[patent_app_number] => 15/576593
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 10790
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15576593
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/576593 | Methods of treating HER2-positive metastatic breast cancer | May 26, 2016 | Issued |